🇺🇸 FDA
Pipeline program

SHR20004

SHR20004-202

Phase 2 small_molecule active

Quick answer

SHR20004 for Obesity is a Phase 2 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).

Program details

Company
Jian Li
Indication
Obesity
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials